Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
99.6K
-
Shares change
-
+1.97K
-
Total reported value, excl. options
-
$6.93M
-
Value change
-
+$184K
-
Number of buys
-
1
-
Number of sells
-
-1
-
Price
-
$69.58
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2023
3 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2023.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.6K shares
of 835M outstanding shares and own 0.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3M shares), RENAISSANCE TECHNOLOGIES LLC (1.86M shares), GOLDMAN SACHS GROUP INC (1.84M shares), Robeco Institutional Asset Management B.V. (1.73M shares), Aikya Investment Management Ltd (1.1M shares), VANGUARD GROUP INC (1.04M shares), DIMENSIONAL FUND ADVISORS LP (829K shares), MORGAN STANLEY (819K shares), Man Group plc (765K shares), and STATE STREET CORP (743K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.